Can magnesium deficiency worsen insulin resistance and glucose handling?

Magnesium is central to both insulin-responsive signaling and cellular energy metabolism. The overall claim is supported with moderate confidence: low magnesium status is associated with poorer insulin sensitivity and dysglycemia, while experimental evidence provides biologically coherent mechanisms.

Clinical evidence

• Prospective cohorts link lower serum magnesium with higher incident type 2 diabetes risk. In Rotterdam, each 0.1-mmol/L lower serum magnesium predicted greater diabetes risk, with insulin resistance estimated to mediate ~29% of the association.
• Intervention evidence is most persuasive in people with documented hypomagnesemia. In adults with prediabetes and low magnesium, 4 months of magnesium chloride improved fasting and post-load glucose and HOMA-IR versus placebo.
• Effects are not uniform: other trials—particularly in unselected prediabetes or metabolic syndrome—found no meaningful improvement in HOMA-IR, insulin, HbA1c, or glucose outcomes. Magnesium correction is therefore not a stand-alone dysglycemia treatment.

Mechanistic evidence

• Magnesium supports ATP predominantly as MgATP, required for kinase reactions, insulin-receptor phosphorylation, oxidative phosphorylation, and ATP generation.
• In short-term magnesium-deficient rat skeletal muscle, insulin-stimulated insulin-receptor β-subunit autophosphorylation and receptor tyrosine-kinase activity each fell by about 50%, alongside an approximately 50% reduction in insulin sensitivity, despite unchanged insulin binding.
• In magnesium-depleted 3T3-L1 adipocytes, reduced Akt activation and impaired GLUT4 translocation were accompanied by roughly 50% lower insulin-stimulated glucose uptake. Prolonged low-magnesium exposure also reduced glucose oxidation and triglyceride synthesis by about 30%.
• Magnesium depletion partially uncoupled rat-liver mitochondrial oxidative phosphorylation; MgCl₂ restored ADP:O ratios, reinforcing a reversible bioenergetic mechanism.

Bottom line

• Magnesium deficiency can plausibly worsen insulin resistance and glucose handling through impaired MgATP-dependent energy/phosphorylation reactions and insulin signaling. Clinically meaningful benefit from repletion is most credible when deficiency is confirmed, rather than as universal supplementation for insulin resistance.